Ankündigung • Feb 27
ASTA Corporation, Annual General Meeting, Mar 26, 2026 ASTA Corporation, Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 145, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea New Risk • Feb 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩120.2b market cap, or US$83.0m). Ankündigung • Feb 11
ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc. ASTA Corporation announced private placement of 1,200,000 common shares at an issue price of KRW 8,720 for gross proceeds of KRW 10,464,000,000 on February 10, 2026. The transaction includes participation from SD Biosensor, Inc. The shares are subject to lock up and are restricted for 1 year. The company will issue shares through third party allotment. The transaction is approved by board of directors of the company and is expected to close on February 24, 2026. Ankündigung • Aug 12
ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding ASTA Corporation announced a private placement to issue 373,140 common shares at an issue price of KRW 5,360 per share for gross proceeds of KRW 2,000,030,400 on August 11, 2025. The transaction will include participation from new investor Lion Skate Fund. The transaction has been approved by shareholders and is expected to close on September 5, 2025 and restricted to a hold period. New Risk • Aug 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Market cap is less than US$100m (₩95.4b market cap, or US$68.6m). Ankündigung • Jul 16
ASTA Corporation has filed a Follow-on Equity Offering in the amount of KRW 999.9808 million. ASTA Corporation has filed a Follow-on Equity Offering in the amount of KRW 999.9808 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 223,210
Price\Range: KRW 4480
Transaction Features: Subsequent Direct Listing Ankündigung • Jul 02
ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd. On June 30, 2025, ASTA Corporation closed the transaction. New Risk • Jun 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (₩71.9b market cap, or US$52.9m). Ankündigung • Mar 07
ASTA Corporation announced that it expects to receive KRW 3 billion in funding ASTA Corporation announced a private placement of Registered Interest Unsecured Private Placement Convertible Bonds for gross proceeds of KRW 3,000,000,000 on March 6, 2025. Maturity date of the Notes is March 10, 2028. Payment date is March 10, 2025. Conversion price of the Notes is KRW 5,165. Interest rate of the Bonds is 1% and Interest rate to maturity is 7%. Ankündigung • Feb 27
ASTA Corporation, Annual General Meeting, Mar 27, 2025 ASTA Corporation, Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 145, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea New Risk • Nov 14
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 13% over the past year. Minor Risks Shareholders have been diluted in the past year (4.5% increase in shares outstanding). Revenue is less than US$5m (₩3.4b revenue, or US$2.4m). Market cap is less than US$100m (₩68.5b market cap, or US$48.8m). New Risk • Sep 30
New major risk - Revenue and earnings growth Revenue has declined by 13% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 13% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (4.5% increase in shares outstanding). Revenue is less than US$5m (₩3.4b revenue, or US$2.6m). Market cap is less than US$100m (₩68.8b market cap, or US$52.6m). Ankündigung • Aug 22
ASTA Corporation announced that it expects to receive KRW 1.00273 billion in funding ASTA Corporation announced a private placement to issue 197,000 common shares at an issue price of KRW 5,090 per share for the gross proceeds of KRW 1,002,730,000 on August 20, 2024. The transaction will include participation from new investors North Data Co., Ltd. 167,000 shares, Jang Junho 10,000 shares and Lee Eunyoung 20,000. The transaction has been approved by shareholder and is expected to close on August 29, 2024. New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (7.8% average weekly change). Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Revenue is less than US$5m (₩3.4b revenue, or US$2.5m). Market cap is less than US$100m (₩63.2b market cap, or US$46.4m). Ankündigung • Jul 04
ASTA Corporation has completed a Follow-on Equity Offering in the amount of KRW 999.73345 million. ASTA Corporation has completed a Follow-on Equity Offering in the amount of KRW 999.73345 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 166,345
Price\Range: KRW 6010 New Risk • Jun 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Revenue is less than US$5m (₩3.4b revenue, or US$2.5m). Market cap is less than US$100m (₩78.6b market cap, or US$56.9m). New Risk • Jan 25
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Revenue is less than US$5m (₩3.4b revenue, or US$2.5m). Market cap is less than US$100m (₩72.6b market cap, or US$54.5m). Reported Earnings • Nov 19
Third quarter 2023 earnings released: ₩88.00 loss per share (vs ₩34.00 loss in 3Q 2022) Third quarter 2023 results: ₩88.00 loss per share (further deteriorated from ₩34.00 loss in 3Q 2022). Revenue: ₩365.2m (down 65% from 3Q 2022). Net loss: ₩1.14b (loss widened 162% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. New Risk • Aug 06
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩1.9b free cash flow). Earnings have declined by 4.0% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.5% increase in shares outstanding). Revenue is less than US$5m (₩3.3b revenue, or US$2.6m). Market cap is less than US$100m (₩108.7b market cap, or US$83.3m). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Is New 90 Day High Low • Jan 15
New 90-day low: ₩4,700 The company is down 33% from its price of ₩7,000 on 16 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 5.0% over the same period. Is New 90 Day High Low • Dec 28
New 90-day low: ₩4,760 The company is down 34% from its price of ₩7,220 on 29 September 2020. The South Korean market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period. Is New 90 Day High Low • Nov 10
New 90-day low: ₩5,150 The company is down 9.0% from its price of ₩5,690 on 12 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is flat over the same period. 
